Florida, January 17, 2018 : The important factors driving the nuclear medicine market are advances in radiotracers and alpha radio immunotherapy-based targeted cancer treatment. SPECT and PET scans usage has been increasing to detect diseases like cancer which is driving the nuclear medicine market. Raising the incidence of cancer and cardiac ailments are also responsible for growing the nuclear medicine market. The nuclear medicine market is also having some restraints such as strict regulatory and global Good Manufacturing Practice guidelines. One of the major restraint is that most of the hospital still rely on conventional diagnostic procedures and not able to shift to nuclear medicine due to cost and availability issues. The life of radiopharmaceuticals is small so that sometimes the use of this is restricted.
The nuclear medicine market is expected to exceed more than US$ 4.5 billion by 2021 growing at around 9.0% CAGR for the given forecast period.
The scope of the report includes a detailed study of global and regional markets for various types of nuclear medicine with the reasons given for variations in the growth of the industry in certain regions.
Browser Full Report @: https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market
This report provides:
1) An overview of the global market for nuclear medicine and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.
3) Identifications of new market opportunities and targeted promotional plans for nuclear medicine.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The Nuclear Medicine Market has been segmented as below:
By Procedural Volume Segment Analysis
By Type Analysis
By Application Analysis
- Bone Metastasis
- Endocrine Tumors
By Regional Analysis
- North America
- Rest of the World
Request Sample Report: https://www.marketresearchengine.com/requestsample/nuclear-medicine-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Nuclear Medicine Market, By Type
7 Nuclear Medicine Market, By Application
8 Nuclear Medicine Market, By Procedural Volume
9 Global Nuclear Medicine Market, By Region
10 Global Nuclear Medicine Market, By Region
11 Competitive Landscape
12 Company Profiles
12.2 Cardinal Health, Inc.
12.3 Mallinckrodt PLC
12.4 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
12.5 Lantheus Medical Imaging, Inc.
12.6 Bayer AG
12.7 Bracco Imaging S.P.A
12.8 Eczacibasi-Monrol Nuclear Products
12.9 Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)
12.10 Advanced Accelerator Applications S.A.
12.11 IBA Molecular
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States